XML 19 R6.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash Flows From Operating Activities:    
Net income (loss) $ (1,193,499) $ (597,225)
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:    
Depreciation and amortization 446,546 452,659
Amortization of debt discount 36,338 42,240
Accretion of asset retirement obligation 3,074 3,074
Common stock issued for services 136,000 0
Common stock payable for directors fees 62,500 87,500
Foreign exchange (gain) loss 0 (12,752)
Other non cash items (598) (656)
Change in:    
Accounts receivable 21,386 (98,712)
Inventories 31,573 202,013
Other current assets 0 4,697
Other assets 1,679 (11,935)
Accounts payable 145,252 91,299
Accrued payroll, taxes and interest 82,845 26,420
Deferred revenue 0 (27,649)
Other accrued liabilities 35,782 36,834
Payables to related party 36,135 10
Net cash provided (used) by operating activities (154,987) 197,817
Cash Flows From Investing Activities:    
Payment received on note receivable - sale of land 400,000
Purchase of properties, plants and equipment (473,578) (174,388)
Net cash used by investing activities (73,578) (174,388)
Cash Flows From Financing Activities:    
Change in checks issued and payable 66,546 82,330
Net proceeds from (payments to) factor (2,720) (5,440)
Advance from related party 227,200 75,000
Payment on advances from related party 0 (75,000)
Proceeds from notes payable to bank 16,081 0
Principal paid on notes payable to bank 0 (1,556)
Principal payments on long-term debt (89,430) (110,872)
Net cash provided (used) by financing activities 217,677 (35,538)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH (10,888) (12,109)
Cash and cash equivalents and restricted cash at beginning of period 113,897 91,332
Cash and cash equivalents and restricted cash at end of period 103,009 79,223
Noncash investing and financing activities:    
Common stock payable issued to directors $ 175,000 $ 175,000